Delivery Order SPE2DR25D1100-SPE2DR26FDC1V
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,668.28 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count) with a completion date of November 17, 2025. This contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. The order will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary operations for federal...
- The Defense Logistics Agency awarded a delivery order valued at $68,803.32 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count packages) on December 16, 2025, with completion scheduled for December 17, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a $11,097.32 delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for Trelegy Ellipta 100-62.5-25 inhalers (60-count supply). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of October 23, 2025, and performance location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $18,398.35 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count units) with a completion date of September 18, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement conducted under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $7,178.56 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count), with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and will be performed at the company's corporate office in Conshohocken, Pennsylvania. Trelegy Ellipta is a prescription maintenance inhaler used to treat chronic obstructive pulmonary...
- The Defense Logistics Agency awarded a delivery order valued at $11,207.26 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count units) on October 31, 2025, with a completion date of November 3, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $5,333.07 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count) on November 17, 2025, with completion expected by November 18, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $4,780.61 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count) on January 9, 2026, with an ultimate completion date of January 12, 2026. This competitive award, made without set-aside designation, is issued under an Indefinite Delivery Contract with DLA Troop Support Medical (contract value up to $999,999,999.00 through December 2026). Trelegy Ellipta is a combination respiratory maintenance...
- The Defense Logistics Agency awarded a delivery order valued at $7,796.67 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count units) on November 24, 2025, with completion targeted for November 25, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trelegy Ellipta is a combination maintenance inhaler used to treat chronic obstructive pulmonary...
- The Defense Logistics Agency awarded a delivery order valued at $12,543.10 to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count package). This firm fixed price, non-competitive delivery order is scheduled for completion by January 6, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Trelegy Ellipta is a combination inhaler containing fluticasone, umeclidinium, and vilanterol,...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FDC1VDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,824.34 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count packaging) on January 28, 2026, with ultimate completion by January 29, 2026. This competitive award, utilizing firm fixed-price pricing with no set-aside designation, represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling delivery of brand-name and generic medications, vaccines, and medical supplies to military healthcare systems worldwide, including the Defense Health Agency and U.S. Coast Guard. Trelegy Ellipta is a combination respiratory therapy medication used in the treatment of chronic obstructive pulmonary disease and asthma, reflecting the Defense Logistics Agency's ongoing procurement of essential pharmaceutical commodities for military treatment facilities and veteran healthcare programs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, maintains a substantial federal contract portfolio with DLA and serves as a critical vendor for military medical supply chain operations. The delivery order will be fulfilled from the awardee's Pennsylvania location, consistent with the company's role as a major pharmaceutical distributor supporting federal medical procurement needs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 1/27/26 |